ライフサイエンスコーパス: total cholesterol

1 y mass index, smoking, diabetes mellitus and total cholesterol).

2 lood pressure, smoking status, diabetes, and total cholesterol.

3 of the measurement of hydrogen peroxide and total cholesterol.

4 s and visceral adipose tissue, and increased total cholesterol.

5 high systolic blood pressure (SBP) and high total cholesterol.

6 which was associated with blood pressure and total cholesterol.

7 d triglycerides but had no effect on LDLs or total cholesterol.

8 little effect on low-density lipoproteins or total cholesterol.

9 high-density lipoprotein (HDL), non-HDL, and total cholesterol.

10 CO by WC was additionally linked to elevated total cholesterol.

11 (0.21 standard deviations, 95% CI 0.01-0.4), total cholesterol (0.21 standard deviations, 95% CI 0.03

12 (0.009 inches; 95% CI, 0.004 to 0.014), and total cholesterol (0.29 mg/dL; 95% CI, 0.13 to 0.45) but

13 and calcium caseinate significantly lowered total cholesterol [-0.26 mmol/L (P = 0.013) and -0.20 mm

14 DL cholesterol (1.14 [1.04-1.25]; p=0.0056), total cholesterol (1.09 [1.01-1.18]; p=0.025), circulati

15 ry biomarkers investigated commonly included total cholesterol (11 studies), LDL, and TG (10 studies

16 d in median changes from baseline in fasting total cholesterol (14 mg/dL vs 10 mg/dL; p=0.034), direc

17 +/- 1 mm Hg, respectively; both P < 0.0008), total cholesterol (-17 +/- 4 mg/dL; P < 0.0001), non-HDL

18 Mean lipid values were as follows: total cholesterol: 177.3 +/- 33.1 mg/dl; LDL-C: 109.9 +/

19 s was 119.98 mg/dL (98.58-141.39 mg/dL); for total cholesterol, 184.74 mg/dL (178.17-191.31 mg/dL); f

20 Women had higher total cholesterol (194 vs 186 mg/dL; P = .027), hemoglob

21 0+/-2.7 versus 26.7+/-2.6 kg/m(2); P<0.001), total cholesterol (199+/-33 versus 192+/-29 mg/dL; P=0.0

22 od pressure (3.78 [95% CI, 2.76-4.81]), high total cholesterol (2.85 [95% CI, 2.38-3.32]), or family

23 perimental groups exhibited increases in: 1) total cholesterol, 2) low-density lipoprotein, and 3) hi

24 pertension (39%; 26-51) followed by elevated total cholesterol (22%; 13-31), detectable HIV RNA (19;

25 (compared with the control, all P < 0.05) in total cholesterol [-3.9% (95% CI: -9.3%, 1.7%) compared

26 3] vs placebo and 34% [26-41] vs ezetimibe), total cholesterol (38% [32-44] vs placebo and 24% [16-31

27 chistosoma mansoni was associated with lower total cholesterol (4.24 vs 4.64 mmol/L; -0.25 [95% CI, -

28 Lipid profile analysis revealed that total cholesterol (4.26 vs. 5.12 mmol/L, p < 0.001) and

29 re +26 mg/dl for triglycerides, -8 mg/dl for total cholesterol, -8 mg/dl for low-density lipoprotein

30 demia remission rates were 93.3% (28/30) for total cholesterol, 89.7% (26/29) for triglycerides, and

31 -13.0% [95% CI, -16.3% to -9.8%]; P < .001), total cholesterol (-9.9% vs 1.3%; difference, -11.2% [95

32 ouths had ideal levels for HDL, non-HDL, and total cholesterol; among adolescents, 46.8% (95% CI, 40.

33 bited a 32 and 44% decrease in the levels of total cholesterol and apolipoprotein B and approximately

34 of SRSF2 in gene regulation, accumulation of total cholesterol and bile acids was prominently observe

35 roadly similar between the sexes, except for total cholesterol and body mass index.

36 Blood-based biomarkers were HbA1c, total cholesterol and C-reactive protein.

37 the PANSS general psychopathology subscale, total cholesterol and education (all p < 0.05) were the

38 , including blood pressure, body-mass index, total cholesterol and glycated-haemoglobin levels.

39 l disparities, which vary by biomarker, with total cholesterol and HbA1c showing the greatest interse

40 -0.880, -0.023; P = 0.039) and a decrease in total cholesterol and HDL cholesterol (beta = 3.766; 95%

41 Measurement of total cholesterol and HDL-C in the nonfasted state is su

42 Adding either total cholesterol and HDL-C, or ApoB and ApoA, to a CVD

43 gy subscore, higher levels of blood glucose, total cholesterol and high-density lipoprotein (HDL) cho

44 Total cholesterol and high-density lipoprotein cholester

45 Preventing elevated total cholesterol and hypertension would avoid the great

46 Butter intake increased total cholesterol and LDL cholesterol more than did oliv

47 The dose-response between nut intake and total cholesterol and LDL cholesterol was nonlinear (P-n

48 be a simple dietary strategy to help manage total cholesterol and LDL cholesterol.

49 ashews into typical American diets decreases total cholesterol and LDL cholesterol.

50 continuation, nondaily statin dosing lowered total cholesterol and LDL-C levels.

51 Higher total cholesterol and LDL-C were associated with faster

52 HIV(+) men had similar baseline total cholesterol and LDL-C, but lower HDL-C and higher

53 imed to study time trends and levels of mean total cholesterol and lipid fractions, and dyslipidaemia

54 3.02), P-trend < 0.001), and those with high total cholesterol and low H(2)O(2) levels.

55 Reduction of total cholesterol and low-density lipoprotein was signif

56 bolic abnormalities, including low levels of total cholesterol and low-density lipoprotein.

57 Total cholesterol and other lipid fractions (except high

58 nds of distinct lipid species in addition to total cholesterol and the other conventional lipid trait

59 We also found an improvement in total cholesterol and triglyceride blood levels without

60 ss index, insulin, insulin resistance index, total cholesterol and triglyceride, and increasing high-

61 ed with higher risk of CHD, independently of total cholesterol and triglycerides (strongest hazard ra

62 p-PLA2 and IL-6 levels, smaller increases in total cholesterol and triglycerides levels, a larger dec

63 lipoprotein, low-density lipoprotein (LDL), total cholesterol and triglycerides on the risk of ALS.

64 ngly, arglabin also reduced plasma levels of total cholesterol and triglycerides to 41% and 42%, resp

65 in cholesterol), 14 (triglycerides), and 19 (total cholesterol and triglycerides).

66 and there were modest increases in levels of total cholesterol and triglycerides.

67 Systemic levels of total cholesterol and use of CLM were measured at study

68 , apoptosis index and GPx) and blood lipids (total cholesterol and VLDL) and the interaction with yac

69 n-diabetic group in addition to age, gender, total-cholesterol and systolic blood pressure (SBP).

70 lucose concentration, height, schizophrenia, total cholesterol, and (in females) age at menarche.

71 luded smoking, blood pressure, diabetes, and total cholesterol, and allowed the effects of sex and ag

72 lower weight, lower HOMA-IR, triglycerides, total cholesterol, and ALT.

73 avioral CVH metrics; fasting plasma glucose, total cholesterol, and blood pressure as biological CVH

74 Ideal CVH status for BMI, total cholesterol, and blood pressure was prevalent in y

75 (body mass index [BMI], healthy diet score, total cholesterol, and blood pressure).

76 ores of low-density lipoprotein-cholesterol, total cholesterol, and body mass index, which were succe

77 rst-trimester serum levels of triglycerides, total cholesterol, and C-reactive protein (CRP).

78 centage, waist circumference, triglycerides, total cholesterol, and C-reactive protein with periodont

79 associated with elevated triglycerides, high total cholesterol, and diabetes.

80 ependent of body mass index, blood pressure, total cholesterol, and fasting plasma glucose, better he

81 ex, physical activity, diet, blood pressure, total cholesterol, and glucose, with higher levels indic

82 smoking status, high-density lipoprotein and total cholesterol, and hemoglobin A(1c).

83 ion measurements of systolic blood pressure, total cholesterol, and high-density lipoprotein choleste

84 reased body temperature, decreased levels of total cholesterol, and increased glucose levels, support

85 high BMI, high fasting plasma glucose, high total cholesterol, and low glomerular filtration rate; 7

86 of malondialdehyde (MDA), glutathione (GSH), total cholesterol, and myeloperoxidase activity (MPO) we

87 diastolic blood pressure, MCM6 and DARS for total cholesterol, and TRIB1 for triglycerides) that wer

88 lower levels of prolactin, fasting glucose, total cholesterol, and triglycerides than risperidone.

89 DL] and low-density lipoprotein-cholesterol, total cholesterol, and triglycerides) and lipoprotein su

90 between ages 6 and 24 years) of systolic BP, total-cholesterol, and smoking associated inversely with

91 High systolic BP, elevated serum total-cholesterol, and smoking from childhood were indep

92 s, systolic blood pressure, fasting glucose, total cholesterol, antihypertensive medication use, glom

93 Hypertension and high total cholesterol are the main NCD drivers (adult preval

94 Hypertension and high total cholesterol are the main NCD drivers (adult preval

95 on (CE) fraction (esterified cholesterol vs. total cholesterol) as an alternative biomarker for liver

96 s in SLC22A3 and low-density lipoprotein and total cholesterol, associations that are missed by stand

97 The continuous variable of total cholesterol at 3 months post implantation and the

98 tudy participants in 2009 to 2011, whose RF (total cholesterol, blood pressure, diabetes mellitus, an

99 Patients with a greater increase in total cholesterol by 3 months post implantation had supe

100 , aspartate aminotransferase (AST), glucose, total cholesterol, cholesterol high-density lipoprotein

101 fatty acid oxidation; (5) increased hepatic total cholesterol concentration and decreased expression

102 olesterol concentration in each phase versus total cholesterol concentration in the sample increases

103 pid packing in the Lo phase was observed for total cholesterol concentration of 20 approximately 30%.

104 her cardiovascular risk factors, and fasting total cholesterol concentrations of 6.5 mmol/L or lower,

105 increased abdominal fat, elevated leptin and total cholesterol concentrations.

106 ay caused mice to excrete up to 60% of their total cholesterol content each day.

107 ition of the membrane that do not change the total cholesterol content, can significantly affect how

108 t 0.08, p < 0.001, in both ELSA and NPHSII), total cholesterol (correlation coefficient 0.46 and 0.34

109 Total cholesterol decreased more in men than women ( P=0

110 ndividual cholesterol esters/cholesterol and total cholesterol esters/cholesterol than those in Group

111 s reaching genome-wide significance: two for total cholesterol (FN1 and SAMM50), two for HDL choleste

112 7 kg/m(2) (0.90 to 1.25) for olanzapine; for total-cholesterol from -0.09 mmol/L (-0.24 to 0.07) for

113 lycerides (from 103 to 75, 69 and 72 mg/dL), total cholesterol (from 267 to 160, 157 and 184 mg/dL),

114 current smoking, hypertension, diabetes, and total cholesterol >/=200 mg/dL) were evaluated in multiv

115 Decreases in serum total cholesterol >1 mmol/L >/=1 year prior to cancer di

116 Lipid abnormalities were identified as total cholesterol >200 mg/dL, 4,558 subjects (11.6%); hi

117 ing a diagnosis of DED given the presence of total cholesterol >200 mg/dL, HDL <40 mg/dL, LDL >130 mg

118 The HYL group had total cholesterol >220 mg/dL or triglycerides >150 mg/dL

119 d but below high-risk threshold), 1 high RF (total cholesterol >=240 mg/dL or treated, blood pressure

120 or for determination of free cholesterol and total cholesterol has been realized using a ZnO-CuO comp

121 d 0.7%, 9.5% and 18.9% of the variability of total cholesterol, HDL cholesterol and triglycerides in

122 essure, serum 25-hydroxyvitamin D [25(OH)D], total cholesterol, HDL cholesterol, apoA-I, apoB, and C-

123 sociations of nonfasting lipid measurements (total cholesterol, HDL-C, non-HDL-C, direct and calculat

124 .01 to 0.06 g/L; P = 0.05) and decreased the total cholesterol-HDL-C ratio by 0.27 (CI, -0.52 to -0.0

125 ory systolic BP, flow-mediated dilation, and total cholesterol/HDL cholesterol.

126 th an increased risk of a coexisting adverse total cholesterol:HDL (TC:HDL) ratio (odds ratio 2.13 (1

127 CI: -1.48%, 0.24%)] was not significant, the total cholesterol:HDL cholesterol ratio was 0.13 (95% CI

128 95% CI: -0.9%, 5.6%), respectively], and the total-cholesterol:HDL-cholesterol ratio [-0.0% (95% CI:

129 -3-methylglutaryl-CoA reductase activity and total cholesterol hepatic levels were 31 and 10% higher,

130 mption, body mass index, and serum levels of total cholesterol, high- and low-density lipoprotein cho

131 parameters such as fasting glucose, insulin, total cholesterol, high-density lipoprotein (HDL) choles

132 standard definitions of abnormal values for total cholesterol, high-density lipoprotein (HDL) choles

133 ircumference (WC), and fasting blood sample (total cholesterol, high-density lipoprotein cholesterol,

134 rmone therapy use, diastolic blood pressure, total cholesterol, high-density lipoprotein cholesterol,

135 Total cholesterol, high-density lipoprotein cholesterol,

136 udy conducted admixture mapping analysis for total cholesterol, high-density lipoprotein cholesterol,

137 and neutrophil counts and increase in hsCRP, total cholesterol, high-density lipoprotein, and low-den

138 beta 0.13, 95%CI: 0.01, 0.32, p = 0.05) and total cholesterol (HRS beta 2.73, 95%CI: 0.09, 4.97, p =

139 c kidney disease, depression, diabetes, high total cholesterol, hypertension, human papillomavirus in

140 c kidney disease, depression, diabetes, high total cholesterol, hypertension, human papillomavirus in

141 longitudinal markers of adiposity and higher total cholesterol in infancy.

142 intermediate sterol pathway metabolites and total cholesterol in macrophages.

143 decreased levels of plasma triglyceride and total cholesterol in ob/ob mice.

144 eroxide (0-5 mM, 2.72 x 10(-6) A.mM(-1)) and total cholesterol in serum from 0 to 9 mM (1.34 x 10(-8)

145 sex, smoking, blood pressure, diabetes, and total cholesterol; in the non-laboratory (office-based)

146 cant improvements in triglycerides, LDL- and total cholesterol, insulin, HbA1c and HOMA-IR (p < 0.005

147 tive global assessment score and lower serum total cholesterol, LDL cholesterol, and albumin concentr

148 BMI x diet interaction were significant for total cholesterol, LDL cholesterol, and apoB ( P values

149 Plasma glucose, total cholesterol, LDL cholesterol, and insulin levels d

150 MI, hemoglobin A1c, systolic blood pressure, total cholesterol, LDL cholesterol, and triglycerides bu

151 Tree nut intake lowers total cholesterol, LDL cholesterol, ApoB, and triglyceri

152 uantitative insulin-sensitivity check index, total cholesterol, LDL cholesterol, HDL cholesterol, or

153 eatment-induced changes in body weight, BMI, total cholesterol, LDL cholesterol, HDL cholesterol, tri

154 Total cholesterol, LDL, HDL, and triglyceride were evalu

155 10, 339, 393, and 317 lipid-related SNPs for total cholesterol, LDL, HDL, and triglycerides, respecti

156 polygenic risk score (PRS) per lipid trait (total cholesterol, LDL, high-density lipoprotein [HDL],

157 Body weight, BMI, fat mass, total cholesterol, LDL-C and triglyceride concentrations

158 ort an association analysis of lipid traits (total cholesterol, LDL-cholesterol, HDL-cholesterol trig

159 iate regression analysis showed neutrophils, total cholesterol, left ventricular mass index, mitral i

160 g populations without marked hyperlipidemia (total cholesterol level <200 mg/dL); absolute benefits w

161 CI, -4.30 to -0.85]; 13 trials [n = 5554]), total cholesterol level (-2.85 mg/dL [95% CI, -4.95 to -

162 (0.5 mum; 95% CI, 0.4-0.6 mum per 10 mmHg), total cholesterol level (0.2 mum; 95% CI, 0.0-0.3 mum pe

163 ght/obesity (body mass index >=25), abnormal total cholesterol level (defined as >=200 mg/dL), diagno

164 Among all youths, the adjusted mean total cholesterol level declined from 164 mg/dL (95% CI,

165 centage of adults with diabetes and the mean total cholesterol level did not vary by income.

166 Total cholesterol level was 3.6 mmol/L (normal, <5.0 mmo

167 s 383 cells/microL), lipid levels (mean [SD] total cholesterol level, 167 [63] vs 190 [54] mg/dL, and

168 esterol level, high triglyceride level, high total cholesterol level, and high glucose levels.

169 ertension, diabetes, cardiovascular disease, total cholesterol level, and other eye conditions.

170 erlipidemia, ischemic heart disease, stroke, total cholesterol level, body mass index, status of smok

171 Furthermore, the variables of age, high total cholesterol level, high glucose level, and abdomin

172 on between the presence of RSL and age, high total cholesterol level, high glucose level, and subcuta

173 ous abdominal fat, total abdominal fat, high total cholesterol level, high low-density lipoprotein (L

174 al site, education level, physical activity, total cholesterol level, high-density lipoprotein choles

175 ent/adult smoking, blood pressure, and serum total cholesterol level.

176 um total cholesterol (mmol/L), and change in total cholesterol level.

177 mansoni infection was associated with lower total cholesterol levels (4.24 vs 4.64 mmol/L, -0.25 [-0

178 ave hypertension (3.9; .1-7.6), or have high total cholesterol levels (9.9; 6.2-13.6).

179 ides in WD-fed LDLr(-/-) mice reduced plasma total cholesterol levels and atherosclerotic plaques.

180 resulted in significant reductions in plasma total cholesterol levels and suppression of diet-induced

181 Total cholesterol levels did not modify the association

182 ow that PF-06446846 reduces plasma PCSK9 and total cholesterol levels in rats following oral dosing.

183 er prevalences of diabetes mellitus and high total cholesterol levels than men.

184 adjustments for confounders, third-trimester total cholesterol levels were associated with a decrease

185 ed Disability Status Scale (EDSS), and serum total cholesterol levels were measured.

186 adipose tissue, low-density lipoproteins and total cholesterol levels).

187 blood pressure, low-density lipoprotein and total cholesterol levels, and adiposity, with evidence o

188 rds modeling, patients achieving recovery of total cholesterol levels, defined as a median or greater

189 a membrane of macrophages without changes to total cholesterol levels.

190 nic deletions associate with reduced LDL and total cholesterol levels.

191 by significant reductions in serum Pcsk9 and total cholesterol levels.

192 The primary outcomes were: blood pressure, total cholesterol, low-density lipoprotein (LDL) cholest

193 hazelnuts, and Brazil nuts) on blood lipids [total cholesterol, low-density lipoprotein (LDL) cholest

194 n 575 women with 1-2 prior pregnancy losses; total cholesterol, low-density lipoprotein cholesterol (

195 The association between lipid markers (total cholesterol, low-density lipoprotein cholesterol [

196 Also, total cholesterol, low-density lipoprotein cholesterol,

197 bolic traits (fasting insulin, triglyceride, total cholesterol, low-density lipoprotein cholesterol,

198 Reductions in total cholesterol, low-density lipoprotein cholesterol,

199 No between-group differences were shown for total cholesterol, low-density lipoprotein cholesterol,

200 Small increases in total cholesterol, low-density lipoprotein, and low-dens

201 Total cholesterol, low-density lipoprotein, high-density

202 ssociated with circulating fasting levels of total cholesterol, low-density lipoprotein-cholesterol,

203 f insulin resistance, including increases in total cholesterol, low-density lipoproteins, high-densit

204 ZNF259/APOA5, KANK2/DOCK6 and NCAN/MAU2 for total cholesterol, LPL, ABCA1, ZNF259/APOA5, LIPC and CE

205 s were divided into 4 groups: low-risk (with total cholesterol <200 mg/dL and no treatment, blood pre

206 king, body mass index <25 kg/m(2), untreated total cholesterol <200 mg/dL, untreated blood pressure <

207 00 mg/dl, glycosylated hemoglobin <5.7%, and total cholesterol <200 mg/dl.

208 e <140/90 mm Hg, fasting glucose <126 mg/dl, total cholesterol <240 mg/dl, low-density lipoprotein ch

209 pressure </=120/</=80 mm Hg, untreated serum total cholesterol <5.18 mmol/l, not smoking, body mass i

210 number of optimized risk factors: nonsmoker, total cholesterol <=4 mmol/L, triglycerides <=1.7 mmol/L

211 Bempedoic acid significantly reduced total cholesterol (MD -14.94%; 95% CI -17.31%, -12.57%;

212 an difference [MD] -1.3, 95% CI -2.3, -0.2), total cholesterol (MD -8.5 mg/dl, 95% CI -9.5, -7.4) and

213 Hg (95% CI: -5.72, -0.22 mm Hg), P = 0.05], total cholesterol [MD: -0.08 mmol/L (95% CI: -0.16, -0.0

214 Compared with controls, cases had higher total cholesterol (mean difference (MD) = 2.4 mg/dL, 95%

215 olorectal cancer risk with statin use, serum total cholesterol (mmol/L), and change in total choleste

216 ween-group differences were also observed in total cholesterol, non-high-density lipoprotein choleste

217 Ps = 10), body mass index (BMI, NSNPs = 32), total cholesterol (NSNPs = 73), HDL-cholesterol (NSNPs =

218 While one SD increase in the PRSs for total cholesterol (odds ratio [OR] = 0.92; 95% confidenc

219 omized to EFV had a reduced risk of elevated total cholesterol (OR 0.45 95% CI: 0.27-0.75, P = .002)

220 4; 95% CI, 0.65-0.84, per 10 mmHg increase), total cholesterol (OR, 0.87; 95% CI, 0.80-0.95, per mmol

221 fasting plasma triglyceride (p < 0.001) and total cholesterol (p < 0.05).

222 found evidence of a smaller causal effect on total cholesterol (P for difference = 0.015) in the >/=5

223 ity was associated with greater increases in total cholesterol (p=0.040) compared with white ethnicit

224 anoate (PFOA) was positively associated with total cholesterol [percent median change per log10-unit

225 roup had a greater (mean +/- SD) decrease in total cholesterol (PY = -0.36 +/- 0.10 mmol/L, LF = -0.3

226 (r=0.36, p=0.0021), BMI (r=0.84, p<0.0001), total-cholesterol (r=0.31, p=0.047), and LDL cholesterol

227 des used for selective detection of free and total cholesterol respectively in the range of 0.12-12.9

228 A mM(-1) cm(-2) towards free cholesterol and total cholesterol respectively with response time of 5 s

229 rs, namely circulating HGA, body mass index, total cholesterol, SAA, and chitotriosidase.

230 lasma lipids, whereas the MFGM diet did not [total cholesterol (+/-SD): +0.30 +/- 0.49 compared with

231 I: 0.04, 0.75), and PFDA was associated with total cholesterol SDS at 18 months (beta = 1.06; 95% CI:

232 showing differential methylation related to total cholesterol (SREBF2), HDL-cholesterol (PHOSPHO1, S

233 this study is to examine whether high serum total cholesterol (STC) is associated with periodontitis

234 Plasma levels of total cholesterol (T-CHL), low density lipoprotein-chole

235 Total cholesterol (T.chol) was also higher among non- fa

236 Adverse concentrations of total cholesterol (TC) (>/= 200 mg/dL), high-density lip

237 (95% confidence interval [CI]) for AMI among total cholesterol (TC) 200-239 stratum were 5.3 (4.89, 5

238 ressure, body mass index (BMI), smoking, and total cholesterol (TC) and high-density lipoprotein chol

239 Total cholesterol (TC) and low-density lipoprotein chole

240 that reduces plasma LDL-cholesterol (LDL-C), total cholesterol (TC) and TG in hyperlipidemic patients

241 lipoprotein (LDL), plasma concentrations of total cholesterol (TC) and triglycerides (TG)).

242 w density lipoprotein cholesterol (LDLc) and total cholesterol (TC) in individuals at higher risk for

243 uced body weight, hepatic and plasma TG, and total cholesterol (TC) levels.

244 rial dyslipidemia, characterized by elevated total cholesterol (TC) or low-density lipoprotein choles

245 ow density lipoprotein cholesterol (LDL), or total cholesterol (TC) were created as the count of risk

246 The HF diet increased the serum leptin and total cholesterol (TC) with respect to the control level

247 lele (varepsilon4) is associated with higher total cholesterol (TC), amplified response to saturated

248 Circulating lipid panels including total cholesterol (TC), HDL cholesterol, and triglycerid

249 d with fasting cholesterol levels, including total cholesterol (TC), high-density lipoprotein cholest

250 Serum triglyceride (TG), total cholesterol (TC), high-density lipoprotein cholest

251 ts in 250 loci significantly associated with total cholesterol (TC), high-density-lipoprotein cholest

252 ic (SBP) and diastolic blood pressure (DBP), total cholesterol (TC), LDL and HDL cholesterol, triglyc

253 ApoA-I, total cholesterol (TC), LDL cholesterol, and HDL cholest

254 total red meat/d on CVD risk factors [blood total cholesterol (TC), LDL cholesterol, HDL cholesterol

255 Total cholesterol (TC), LDL cholesterol, triacylglycerol

256 carriers had higher plasma concentrations of total cholesterol (TC), low-density lipoprotein choleste

257 Total cholesterol (TC), low-density lipoprotein choleste

258 t role in modulating lipid traits, including total cholesterol (TC), low-density lipoprotein choleste

259 between NPs and components of lipid profile [total cholesterol (TC), low-density lipoprotein choleste

260 Serum levels of total cholesterol (TC), TG, low-density lipoprotein, and

261 B-vitamin concentrations are associated with total cholesterol (TC), triglycerides (TG), and lipoprot

262 PS consumption lowered total cholesterol (TC; -0.25 +/- 0.05 mmol/L; P < 0.0001

263 of population-based studies in which lipid (total cholesterol [TC; 86 studies; 168,553 people], HDL-

264 low-density lipoprotein cholesterol [LDL-C], total cholesterol [TC]) were studied as continuous varia

265 ence on 12 inflammatory biomarkers-LDL, HDL, total cholesterol, TG, HbA1c, Apo AI, Apo AII, Apo B, CR

266 group, BOP was significantly correlated with total cholesterol, the ratio of total cholesterol to hig

267 ect LDL (21 mg/dL vs 14 mg/dL; p=0.004), and total cholesterol to HDL ratio (-0.1 vs -0.3; p=0.007) a

268 hange scores for LDL-cholesterol (p<0.0001), total cholesterol to HDL-cholesterol ratio (p<0.0001), a

269 (sex, age, cohort status, diabetes duration, total cholesterol to HDL-cholesterol ratio, smoking, sys

270 en the two groups in change from baseline in total cholesterol to HDL-cholesterol ratio.

271 ascular and cardiac events, digoxin use, and total cholesterol to high-density lipoprotein cholestero

272 d diastolic blood pressure, ratio of fasting total cholesterol to high-density lipoprotein cholestero

273 The total cholesterol to high-density lipoprotein cholestero

274 related with total cholesterol, the ratio of total cholesterol to high-density lipoprotein cholestero

275 a intake reduced at significant level plasma total-cholesterol (total-c), LDL-c, and oxidized-LDL to

276 cantly decreased plasma insulin, HOMA index, total cholesterol, triglyceride, LDL and visceral fat.

277 As a result, total cholesterol, triglyceride, low-density lipid, high

278 m exhibited a significant decrease in plasma total cholesterol, triglycerides and LDL cholesterol com

279 rotein cholesterol, systolic blood pressure, total cholesterol, triglycerides and waist circumference

280 either directly measured or calculated from total cholesterol, triglycerides, and apoA-I.

281 h higher blood pressure, insulin resistance, total cholesterol, triglycerides, and C-reactive protein

282 pressure, LDL cholesterol, HDL cholesterol, total cholesterol, triglycerides, and fasting blood gluc

283 Sweden, with measurements of serum glucose, total cholesterol, triglycerides, apolipoprotein B (apoB

284 blood pressure, low-density lipoprotein- and total cholesterol, triglycerides, fasting glucose, body

285 inistration of AFSE to diabetic mice reduced total cholesterol, triglycerides, LDL-cholesterol, and t

286 ons of LDL cholesterol, non-HDL cholesterol, total cholesterol, triglycerides, lipoprotein(a), and HD

287 y lipoprotein cholesterol (HDL-cholesterol), total cholesterol, triglycerides, measures of body fatne

288 h fat-fed mice without affecting circulating total cholesterol, triglycerides, or glycerol levels.

289 were tobacco smoking, hypertension, elevated total cholesterol, type 2 diabetes, renal impairment (st

290 All fibres reviewed reduced total cholesterol, very low-density lipoprotein choleste

291 ubjects, every 10-mg/dL increase in baseline total cholesterol was associated with a 3.6% decrease in

292 Furthermore, total cholesterol was associated with decreased hippocam

293 Total cholesterol was inversely associated with incident

294 ensity lipoprotein (HDL), triglycerides, and total cholesterol were also changed.

295 y lipoprotein, high-density lipoprotein, and total cholesterol were not associated with microorganism

296 liver were reduced, whereas tissue levels of total cholesterol were unchanged.

297 es in the association of body mass index and total cholesterol with AF need to be evaluated for under

298 -based) risk score, we replaced diabetes and total cholesterol with BMI.

299 wer fecal cholesterol levels and lower serum total cholesterol with effects comparable to those attri

300 ources, red meat yielded lesser decreases in total cholesterol (WMD, 0.264 mmol/L; 95% CI, 0.144-0.38